The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers : Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 4, 2020
March 4, 2020
fdd76b2b-bf3b-4f6d-9988-59d75e496a17
Related Documents
Questions and Answers on Biosimilar Development and the BPCI Act Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 17, 2021Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Interpretation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009 : Guidance for Industry
Guidance DocumentDecember 12, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox